SEC Form 4 · accession 0001193125-26-255624
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Couling
Officer — SVP, Entertainment
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 4:43 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Jun 1, 2026 | M | 7,666 | $45.50 | A | 126,393 | D | |
| Class A Common StockF3,F1 | Jun 1, 2026 | S | 7,158 | $55.5868 | D | 119,235 | D | |
| Class A Common StockF1 | Jun 1, 2026 | S | 508 | $56.16 | D | 118,727 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $45.50 | Jun 1, 2026 | M | 7,666 | D | — | Dec 15, 2026 | Class A Common Stock | 7,666 | 30,668 | D |
Explanation of responses
- F1Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- F2Shares include 374 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
- F3The shares were sold in multiple transactions at prices ranging from $55.15 to $56.105 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026.
- F4This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.